logo
Plus   Neg
Share
Email

Glass Lewis Recommends Express Scripts Stockholders Vote 'FOR' Merger With Cigna

Express Scripts (ESRX) said that Glass, Lewis & Co., LLC, an independent proxy advisory firm, has recommended that Express Scripts stockholders vote "FOR" Express Scripts' merger agreement with Cigna (CI) at Express Scripts' upcoming special meeting of stockholders scheduled for August 24, 2018.

In its report dated August 10, 2018, Glass Lewis said, "In our view, the proposed Cigna/Express Scripts merger is based on sound strategic and financial logic and, in light of management's projections and other considerations, reasonably likely to generate significant value for shareholders of both Cigna and Express Scripts."

The transaction is expected to be completed by December 31, 2018. It remains subject to the approval of Cigna and Express Scripts stockholders and the satisfaction of customary closing conditions, including applicable regulatory approvals.

Separately, Cigna announced that Glass Lewis & Co. has joined Institutional Shareholder Services in recommending that Cigna shareholders vote to approve the proposed acquisition of Express Scripts at the Company's upcoming special meeting scheduled for August 24, 2018.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased. Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Palantir Technologies Inc., the Silicon Valley big data analytics company that has handled U.S. government's certain sensitive projects, said it has confidentially filed documents with the Securities and Exchange Commission to go public. In a statement, the company said the proposed public listing of its Class A common stock is expected to take place after the SEC completes its review process.
Follow RTT